Clinical Trial Update: Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients [NA]

View source ↗

Summary

A clinical trial update describing pharmacogenomic-guided antidepressant prescribing for cancer patients. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety
• Cancer
• Depressive Disorder
• Generalized Anxiety Disorder
• Major Depressive Disorder

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Depression, Anxiety | NA | Status: COMPLETED